Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Pseudolymphomatous Reaction to Red Tattoo Pigment.

Saulite I, Pekar-Lukacs A, Kerl K, Cozzio A, Hoetzenecker W, Guenova E.

Case Rep Dermatol. 2018 Jun 14;10(2):162-168. doi: 10.1159/000489875. eCollection 2018 May-Aug.

2.

PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma.

Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Baierl A, Kazakov D, Michal M, French LE, Hoetzenecker W, Schatton T, Asari R, Preusser M, Gnant M, Guenova E, Schoppmann SF.

Oncoimmunology. 2018 Mar 13;7(6):e1435226. doi: 10.1080/2162402X.2018.1435226. eCollection 2018.

PMID:
29872575
3.

Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.

Hanfstingl K, Pekar-Lukacs A, Motz R, Guenova E, Hoetzenecker W.

Case Rep Dermatol. 2018 May 2;10(2):97-100. doi: 10.1159/000488902. eCollection 2018 May-Aug.

4.

Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study.

Brüggen MC, Kerl K, Haralambieva E, Schanz U, Chang YT, Ignatova D, Dummer R, Cozzio A, Hoetzenecker W, French LE, Guenova E.

Acta Derm Venereol. 2018 Apr 24. doi: 10.2340/00015555-2950. [Epub ahead of print]

5.

Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.

Luder CM, Nordmann TM, Ramelyte E, Mühleisen B, Kerl K, Guenova E, Dummer R.

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):926-934. doi: 10.1111/jdv.14794. Epub 2018 Jan 31. Review.

PMID:
29341328
6.

Individualized treatment approaches for Langerhans cell histiocytosis.

Roider E, Signer C, Fehrenbacher B, Metzler G, Schaller M, Kamarachev J, Kerl K, Balabanov S, Jochum W, Hoetzenecker W, Cozzio A, French LE, Dummer R, Guenova E.

Br J Dermatol. 2018 Jun;178(6):1423-1424. doi: 10.1111/bjd.16171. Epub 2018 Mar 23. No abstract available.

PMID:
29194560
7.

Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.

Stoffel E, Maier H, Riedl E, Brüggen MC, Reininger B, Schaschinger M, Bangert C, Guenova E, Stingl G, Brunner PM.

Br J Dermatol. 2018 May;178(5):1151-1162. doi: 10.1111/bjd.16126. Epub 2018 Mar 6.

PMID:
29143979
8.

Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab.

Saulite I, Guenova E, Hoetzenecker W.

Curr Probl Dermatol. 2018;53:70-81. doi: 10.1159/000478079. Epub 2017 Nov 7.

PMID:
29131039
9.

Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.

Saulite I, Hoetzenecker W, Guenova E, Schmid-Grendelmeier P, Glatz M.

Int Arch Allergy Immunol. 2017;174(3-4):190-199. doi: 10.1159/000481255. Epub 2017 Nov 9.

PMID:
29130986
10.

Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.

Kolios AGA, Gübeli A, Meier B, Maul JT, Kündig T, Nilsson J, Hafner J, Guenova E, Kerl K, Anliker M, Kempf W, Navarini AA, French LE, Cozzio A.

Dermatology. 2017;233(4):268-276. doi: 10.1159/000481432. Epub 2017 Nov 7.

11.

TLR4 as a negative regulator of keratinocyte proliferation.

Iotzova-Weiss G, Freiberger SN, Johansen P, Kamarachev J, Guenova E, Dziunycz PJ, Roux GA, Neu J, Hofbauer GFL.

PLoS One. 2017 Oct 5;12(10):e0185668. doi: 10.1371/journal.pone.0185668. eCollection 2017.

12.

PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer.

Kollmann D, Schweiger T, Schwarz S, Ignatova D, Chang YT, Lewik G, Schoppmann SF, Hoetzenecker W, Klepetko W, Guenova E, Hoetzenecker K.

Oncoimmunology. 2017 Aug 18;6(9):e1331194. doi: 10.1080/2162402X.2017.1331194. eCollection 2017.

PMID:
28932634
13.

CME-Antworten.

Rebsamen U, Guenova E, Vallelian F.

Praxis (Bern 1994). 2017 Sep;106(19):1075. doi: 10.1024/1661-8157/a002776. German. No abstract available.

PMID:
28927366
14.

CME: Erythema nodosum.

Rebsamen U, Guenova E, Vallelian F.

Praxis (Bern 1994). 2017 Sep;106(18):973-979. doi: 10.1024/1661-8157/a002775. German. No abstract available.

PMID:
28875753
15.

Comparison of pyoderma gangrenosum and Martorell hypertensive ischaemic leg ulcer in a Swiss cohort.

Kolios AGA, Hafner J, Luder C, Guenova E, Kerl K, Kempf W, Nilsson J, French LE, Cozzio A.

Br J Dermatol. 2018 Feb;178(2):e125-e126. doi: 10.1111/bjd.15901. Epub 2018 Jan 7. No abstract available.

PMID:
28832960
16.

Dome-shaped Papules on the Left Flank: A Quiz. Cutaneous Rosai-Dorfman Disease (sinus histiocytosis with massive lymphadenopathy.

Roenneberg S, Hegyi I, Kempf W, Kerl K, Guenova E.

Acta Derm Venereol. 2018 Jan 12;98(1):165-166. doi: 10.2340/00015555-2765. No abstract available.

17.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.

Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR, Gniadecki R.

J Am Acad Dermatol. 2017 Oct;77(4):719-727. doi: 10.1016/j.jaad.2017.05.036. Epub 2017 Jul 11.

PMID:
28709694
18.

Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome).

Mangana J, Guenova E, Kerl K, Urosevic-Maiwald M, Amann VC, Bayard C, Dummer R, French LE.

Case Rep Dermatol. 2017 Mar 21;9(1):74-79. doi: 10.1159/000458752. eCollection 2017 Jan-Apr.

19.

Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.

Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Paireder M, Kristo I, Kazakov D, Michal M, Cozzio A, Hoetzenecker W, Schatton T, Asari R, Preusser M, Guenova E, Schoppmann SF.

Ann Surg Oncol. 2017 Sep;24(9):2698-2706. doi: 10.1245/s10434-017-5858-7. Epub 2017 Apr 20.

20.

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.

Thurneysen S, Cheng PF, Nagel HW, Kunz M, Jaberg-Bentele N, Nägeli M, Ziegler M, Guenova E, Goldinger SM, Mangana J, Levesque MP, Dummer R.

Br J Dermatol. 2016 Nov;175(5):966-978. doi: 10.1111/bjd.14727. Epub 2016 Sep 19.

21.

Depth and Patterns of Adnexal Involvement in Primary Extramammary (Anogenital) Paget Disease: A Study of 178 Lesions From 146 Patients.

Konstantinova AM, Shelekhova KV, Stewart CJ, Spagnolo DV, Kutzner H, Kacerovska D, Plaza JA, Suster S, Bouda J, Pavlovsky M, Kyrpychova L, Michal M, Guenova E, Kazakov DV.

Am J Dermatopathol. 2016 Nov;38(11):802-808.

22.

Expression of inflammatory cytokines in psoriatic nails.

Saulite I, Pilmane M, Guenova E, Kisis J.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e210-e212. doi: 10.1111/jdv.13970. Epub 2016 Oct 4. No abstract available.

PMID:
27632414
23.

Cutaneous Oncology: From Research to Diagnosis and Management.

Saulite I, Roider E, Darlenksi R, Jalili A, Guenova E.

Biomed Res Int. 2016;2016:7819428. doi: 10.1155/2016/7819428. Epub 2016 Jun 2. No abstract available.

24.

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.

Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U.

Biomed Res Int. 2016;2016:9717530. doi: 10.1155/2016/9717530. Epub 2016 May 17. Review.

25.

Toxic epidermal necrolysis.

Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E, Cozzio A, French LE.

F1000Res. 2016 May 20;5. pii: F1000 Faculty Rev-951. doi: 10.12688/f1000research.7574.1. eCollection 2016. Review.

26.

Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.

Sönnichsen A, Saulite I, Mangana J, Kerl K, Mehra T, Desislava I, Chang YT, Petrausch U, Schmid-Grendelmeier P, Hoetzenecker W, Cozzio A, Guenova E.

J Dermatolog Treat. 2016 Oct;27(5):436-8. doi: 10.3109/09546634.2015.1136048. Epub 2016 Feb 10.

PMID:
26864191
27.

Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations.

Konstantinova AM, Michal M, Kacerovska D, Spagnolo DV, Stewart CJ, Kutzner H, Zelger B, Plaza JA, Denisjuk N, Hejda V, Shelekhova K, Bisceglia M, Danis D, Zamecnik M, Kerl K, Guenova E, Kazakov DV.

Am J Dermatopathol. 2016 Aug;38(8):598-607. doi: 10.1097/DAD.0000000000000495.

28.

Infundibulocystic Structures and Prominent Squamous Metaplasia in Sebaceoma-A Rare Feature. A Clinicopathologic Study of 10 Cases.

Flux K, Kutzner H, Rütten A, Plaza JA, Gasparov S, Michal M, Guenova E, Kazakov DV.

Am J Dermatopathol. 2016 Sep;38(9):678-82. doi: 10.1097/DAD.0000000000000494.

29.

Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid.

Mehra T, Guenova E, Dechent F, Würth F, Zierhut M, Röcken M, Schaller M, Deuter C.

J Dtsch Dermatol Ges. 2015 Dec;13(12):1268-74. doi: 10.1111/ddg.12716.

PMID:
26612798
30.

Adverse cutaneous drug eruptions: current understanding.

Hoetzenecker W, Nägeli M, Mehra ET, Jensen AN, Saulite I, Schmid-Grendelmeier P, Guenova E, Cozzio A, French LE.

Semin Immunopathol. 2016 Jan;38(1):75-86. doi: 10.1007/s00281-015-0540-2. Epub 2015 Nov 9. Review.

PMID:
26553194
31.

Expression of CD164 on Malignant T cells in Sézary Syndrome.

Guenova E, Ignatova D, Chang YT, Contassot E, Mehra T, Saulite I, Navarini AA, Mitev V, Dummer R, Kazakov DV, French LE, Hoetzenecker W, Cozzio A.

Acta Derm Venereol. 2016 May;96(4):464-7. doi: 10.2340/00015555-2264.

32.

Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study.

Kunz M, Urosevic-Maiwald M, Goldinger SM, Frauchiger AL, Dreier J, Belloni B, Mangana J, Jenni D, Dippel M, Cozzio A, Guenova E, Kamarachev J, French LE, Dummer R.

J Eur Acad Dermatol Venereol. 2016 Feb;30(2):293-8. doi: 10.1111/jdv.13444. Epub 2015 Oct 27.

PMID:
26507685
33.

Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.

Kleffel S, Posch C, Barthel SR, Mueller H, Schlapbach C, Guenova E, Elco CP, Lee N, Juneja VR, Zhan Q, Lian CG, Thomi R, Hoetzenecker W, Cozzio A, Dummer R, Mihm MC Jr, Flaherty KT, Frank MH, Murphy GF, Sharpe AH, Kupper TS, Schatton T.

Cell. 2015 Sep 10;162(6):1242-56. doi: 10.1016/j.cell.2015.08.052.

34.

Inpatient Treatment for Severe Nonsurgical Dermatological Disorders: Prevalence, Care Infrastructure and Reimbursement in Switzerland.

Mehra T, Hoetzenecker W, Moos R, Volbracht J, Guenova E, French LE, Hafner J.

Dermatology. 2015;231(3):260-8. doi: 10.1159/000437223. Epub 2015 Aug 19.

35.

The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis.

Bentele-Jaberg N, Guenova E, Mehra T, Nägeli M, Chang YT, Cozzio A, French LE, Hoetzenecker W.

Dermatology. 2015;231(2):99-102. doi: 10.1159/000433423. Epub 2015 Jul 1.

36.

IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Guenova E, Skabytska Y, Hoetzenecker W, Weindl G, Sauer K, Tham M, Kim KW, Park JH, Seo JH, Ignatova D, Cozzio A, Levesque MP, Volz T, Köberle M, Kaesler S, Thomas P, Mailhammer R, Ghoreschi K, Schäkel K, Amarov B, Eichner M, Schaller M, Clark RA, Röcken M, Biedermann T.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2163-8. doi: 10.1073/pnas.1416922112. Epub 2015 Feb 2.

37.

Recent advances in primary cutaneous T-cell lymphoma.

DeSimone JA, Sodha P, Ignatova D, Dummer R, Cozzio A, Guenova E.

Curr Opin Oncol. 2015 Mar;27(2):128-33. doi: 10.1097/CCO.0000000000000161. Review.

38.

Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells.

Skabytska Y, Wölbing F, Günther C, Köberle M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T, Rammensee HG, Schaller M, Röcken M, Götz F, Biedermann T.

Immunity. 2014 Nov 20;41(5):762-75. doi: 10.1016/j.immuni.2014.10.009. Epub 2014 Nov 13.

39.

Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma.

Mehra T, Grözinger G, Mann S, Guenova E, Moos R, Röcken M, Claussen CD, Dummer R, Clasen S, Naumann A, Garbe C.

PLoS One. 2014 Nov 10;9(11):e112535. doi: 10.1371/journal.pone.0112535. eCollection 2014.

40.

Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine.

Amann VC, Dreier J, Ignatova D, Kamarashev J, Kerl K, Kempf W, Pascolo S, Dummer R, Cozzio A, Guenova E.

Acta Derm Venereol. 2015 May;95(5):602-3. doi: 10.2340/00015555-2002. No abstract available.

41.

Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.

Mehra T, Ikenberg K, Moos RM, Benz R, Nair G, Schanz U, Haralambieva E, Hoetzenecker W, Dummer R, French LE, Guenova E, Cozzio A.

JAMA Dermatol. 2015 Jan;151(1):73-7. doi: 10.1001/jamadermatol.2014.1629.

PMID:
25317818
42.

Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma.

Guenova E, Schanz S, Hoetzenecker W, DeSimone JA, Mehra T, Voykov B, Urosevic-Maiwald M, Berneburg M, Dummer R, French LE, Kerl K, Kamarashev J, Fierlbeck G, Cozzio A.

Br J Dermatol. 2014 Oct;171(4):891-4. doi: 10.1111/bjd.13053. Epub 2014 Sep 2.

PMID:
24725144
43.

Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.

Kaesler S, Volz T, Skabytska Y, Köberle M, Hein U, Chen KM, Guenova E, Wölbing F, Röcken M, Biedermann T.

J Allergy Clin Immunol. 2014 Jul;134(1):92-9. doi: 10.1016/j.jaci.2014.02.017. Epub 2014 Apr 1.

PMID:
24698321
44.

Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Schlapbach C, Gehad A, Yang C, Watanabe R, Guenova E, Teague JE, Campbell L, Yawalkar N, Kupper TS, Clark RA.

Sci Transl Med. 2014 Jan 15;6(219):219ra8. doi: 10.1126/scitranslmed.3007828.

45.

Incidental finding of lamellar calcification of the falx cerebri leading to the diagnosis of gorlin-goltz syndrome.

Saulite I, Voykov B, Mehra T, Hoetzenecker W, Guenova E.

Case Rep Dermatol. 2013 Oct 19;5(3):301-3. doi: 10.1159/000356146. eCollection 2013.

46.

Novel therapies for cutaneous T-cell lymphoma: what does the future hold?

Guenova E, Hoetzenecker W, Rozati S, Levesque MP, Dummer R, Cozzio A.

Expert Opin Investig Drugs. 2014 Apr;23(4):457-67. doi: 10.1517/13543784.2014.876407. Epub 2014 Jan 8. Review.

PMID:
24397291
47.

Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome?

Voykov B, Deuter C, Zierhut M, Leitritz MA, Guenova E, Doycheva D.

Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):485-9. doi: 10.1007/s00417-013-2558-2. Epub 2014 Jan 5. Erratum in: Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):1023. Guenova-Hötzenecker, Emmanuella [corrected to Guenova, Emmanuella].

PMID:
24390401
48.

Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.

Schweiger T, Kollmann D, Nikolowsky C, Traxler D, Guenova E, Lang G, Birner P, Klepetko W, Ankersmit HJ, Hoetzenecker K.

Eur J Cardiothorac Surg. 2014 Jul;46(1):92-9. doi: 10.1093/ejcts/ezt542. Epub 2013 Dec 8.

PMID:
24321995
49.

Treatment of pyoderma gangrenosum with topical factor XIII.

Hoetzenecker W, Guenova E, Mitev V, Schanz S, Ulmer A, Fierlbeck G.

Eur J Dermatol. 2013 Sep-Oct;23(5):653-7. doi: 10.1684/ejd.2013.2147.

PMID:
24135449
50.

Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas.

Dummer R, Rozati S, Guenova E, Cozzio A.

Future Oncol. 2013 Aug;9(8):1061-4. doi: 10.2217/fon.13.87. No abstract available.

PMID:
23902236

Supplemental Content

Loading ...
Support Center